GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
1.380
-0.020 (-1.43%)
At close: Mar 25, 2025, 4:00 PM
1.370
-0.010 (-0.72%)
After-hours: Mar 25, 2025, 4:30 PM EST
GeoVax Labs Employees
GeoVax Labs had 17 employees as of December 31, 2023. The number of employees increased by 3 or 21.43% compared to the previous year.
Employees
17
Change (1Y)
3
Growth (1Y)
21.43%
Revenue / Employee
$181,774
Profits / Employee
-$1,430,709
Market Cap
13.02M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
GOVX News
- 3 months ago - GeoVax Receives Notice of Allowance For Cancer Vaccine Patent - GlobeNewsWire
- 4 months ago - GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference - GlobeNewsWire
- 4 months ago - GeoVax Labs, Inc. (GOVX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 5 months ago - GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024 - GlobeNewsWire
- 6 months ago - GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - GlobeNewsWire
- 7 months ago - GeoVax to Participate in Upcoming Investor Conferences in September - GlobeNewsWire
- 7 months ago - GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market - GlobeNewsWire